Skip to main content

Tempest Therapeutics, Inc.

TPST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001544227

No open-market purchases or sales by Tempest Therapeutics, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q3 2026, worth $682.2K in total; no superinvestor holds it.

Holders of 5% or more of TPST

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Tempest Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of TPST
HolderLatest formStakeChangeFirst filedLatest filingFiling
Angel Matthew13D/A37.40%5.53M shares+1.50 ppfrom 35.90%Feb 10, 20262 filingsMar 25, 2026SEC
Sabby Management, LLC13G9.90%492.2K sharesNewJan 21, 20261 filingJan 21, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

30 Schedule 13D and 13G filings on Tempest Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on TPST
Filed (ET)FilerFormStakeChangeEvent dateFiling
Apr 2, 20264:30 PM ETVersant Venture Capital VI, L.P.and 8 others13D/A1.10%163.0K shares−2.60 ppfrom 3.70%Below 5%Mar 30, 2026SEC
Mar 25, 20265:33 PM ETAngel Matthew13D/A37.40%5.53M shares+1.50 ppfrom 35.90%Mar 24, 2026SEC
Feb 10, 20265:15 PM ETAngel Matthew13D35.90%4.84M sharesNewFeb 3, 2026SEC
Jan 21, 20269:27 AM ETSabby Management, LLCand 2 others13G9.90%492.2K sharesNewDec 31, 2025SEC
Aug 13, 20257:14 PM ETVersant Venture Capital VI, L.P.and 8 others13D/A3.70%163.0K shares−1.10 ppfrom 4.80%Below 5%Aug 11, 2025SEC
Feb 11, 20255:58 PM ETVersant Venture Capital VI, L.P.and 8 others13D/A4.80%2.12M shares–Below 5%Nov 12, 2024SEC
Aug 12, 2024Versant Venture Capital VI, L.P.13D/AOld format–––SEC
May 13, 2024Versant Venture Capital VI, L.P.13D/AOld format–––SEC
Feb 14, 2024Rock Springs Capital Management LP13G/AOld format–––SEC
Feb 14, 2024EcoR1 Capital, LLC13G/AOld format–––SEC
Feb 9, 2024FMR LLC13G/AOld format–––SEC
Feb 8, 2024Versant Venture Capital VI, L.P.13D/AOld format–––SEC
Nov 9, 2023Versant Venture Capital VI, L.P.13D/AOld format–––SEC
Feb 14, 2023Rock Springs Capital Management LP13G/AOld format–––SEC
Feb 14, 2023EcoR1 Capital, LLC13GOld format–New–SEC
May 9, 2022Versant Venture Capital VI, L.P.13DOld format–––SEC
Feb 17, 2022LAV Regulus Ltd13GOld format–New–SEC
Feb 14, 2022Ikarian Capital, LLC13G/AOld format–––SEC
Feb 14, 2022Roche Finance Ltd13G/AOld format–––SEC
Feb 14, 2022Citadel Advisors LLC13G/AOld format–––SEC
Feb 11, 2022Versant Venture Capital VI, L.P.13GOld format–New–SEC
Jan 3, 2022Rock Springs Capital Management LP13GOld format–––SEC
Jul 15, 2021Rock Springs Capital Management LP13G/AOld format–––SEC
Jul 8, 2021Rock Springs Capital Management LP13GOld format–New–SEC
Jul 6, 2021FMR LLC13GOld format–New–SEC
Apr 13, 2021New Enterprise Associates 15, L.P.13D/AOld format–––SEC
Apr 7, 2021Ikarian Capital, LLC13GOld format–New–SEC
Mar 16, 2021Citadel Advisors LLC13GOld format–New–SEC
Feb 16, 2021Great Point Partners LLC13G/AOld format–––SEC
Feb 16, 2021Roche Finance Ltd13G/AOld format–––SEC

Form 144: proposed insider sales

3 notices from officers, directors and other affiliates planning to sell Tempest Therapeutics, Inc. shares, newest first.

Form 144 notices for TPST
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Aug 13, 20248:03 AM ETVersant Venture Capital VI, L.P.Owner388.0K$427.0KAug 12, 2024Jones Trading Institutional Services LLCSEC
Aug 9, 20243:41 PM ETVersant Venture Capital VI, L.P.10% stockholder400.0K$7.21MAug 8, 2024BTIG, LLCSEC
Nov 2, 20234:16 PM ETDubensky Thomas W.Officer · Director30.0K$131.5KOct 25, 2023Merrill LynchSEC